What does caryophyllene do in the body?
Beta-caryophyllene (BCP) is a sesquiterpene found in black pepper, cloves, hops, rosemary, oregano, and cannabis. Its standout outcome is CB2 receptor binding, which places it in the endocannabinoid system along with THC and CBD. It does not cause a high because it leaves CB1 alone.
Beyond the CB2 pathway, BCP interacts with peroxisome proliferator-activated receptors (PPARs) and shows antioxidant activity in lab models. Researchers call it a dietary cannabinoid for that reason.
- Source plants: black pepper, cloves, cinnamon, hops, rosemary, copaiba oil
- Receptor target: CB2 (agonist)
- Regulatory status: FDA GRAS food additive
- Psychoactivity: none reported at normal doses
Caryophyllene outcomes by health area
Most evidence comes from cell cultures and rodent studies. Human trials exist but stay small, so treat the list below as early signals rather than settled results.
Inflammation and pain
BCP activates CB2 receptors on immune cells, which can lower cytokine release in animal models. Rodent studies on arthritis, colitis, and nerve pain report less swelling and lower pain scores after BCP dosing. Human data for pain is thin, and most of it comes from topical blends.
Anxiety and mood
Several mouse studies show BCP reduces anxiety-like behavior in maze tests, with effects that overlap with low-dose benzodiazepine responses. The proposed route is CB2 signaling plus serotonin involvement. Human trials are needed before anyone can claim a clinical anxiety benefit.
Gut, liver, and metabolic research
Animal work links BCP to less gut inflammation and better intestinal barrier function. One small human study on BCP and liver markers reported changes in some participants, but the sample was tiny. That is not proof it treats liver disease.
Skin and topical use
Copaiba oil, which can run 50% or more beta-caryophyllene, appears in skin products for irritation and dryness. Mouse studies on skin inflammation support a mild calming effect. Topical CBD balms often carry caryophyllene for the same reason.
What changes caryophyllene outcomes?
Four factors shape what you get from a caryophyllene product.
- Dose: animal research doses often run 10 to 100 mg/kg, far above what a drop of oil delivers.
- Delivery: inhaled and topical routes reach tissue faster than a swallowed capsule.
- Formula: fat improves absorption of terpenes and cannabinoids.
- Company: other terpenes and cannabinoids in full-spectrum oil may add to or blunt an effect.
Nobody has a clean answer for human bioavailability yet. That gap explains why animal results do not translate straight to a bottle of CBD oil.
What the research does and does not show
There is broad agreement that BCP binds CB2 and modulates inflammation in lab models. There is no agreement on dosing, bioavailability, or long-term safety in humans.
- Solid: receptor binding, antioxidant activity, GRAS status
- Promising: pain, anxiety, and gut inflammation in animals
- Unproven: human dosing, cancer outcomes, addiction treatment
Search results that promise cures oversell the data. The honest summary is that caryophyllene outcomes look real in animals and early human work, and unresolved in clinical practice.
How much caryophyllene is in CBD oil?
Full-spectrum hemp extracts carry caryophyllene because the plant makes it. Concentrations shift with cultivar, harvest time, and extraction method, and they often land between 0.1% and 2% of the finished oil. Isolates and broad-spectrum products stripped of terpenes may contain none.
Check the terpene panel on the certificate of analysis (COA) to see the real number for the batch you buy. A COA without a terpene section tells you nothing about caryophyllene content.
Does caryophyllene get you high?
No. BCP has no reported psychoactive effect and does not bind CB1 with meaningful strength. Some users report body calm after high-caryophyllene products, but that is a subjective response, not intoxication.
Food amounts from pepper and cloves sit far below any dose used in research. No toxicity signal appears in the GRAS review for food use.
How to read a lab report for caryophyllene
- Look for a terpene profile, not just a cannabinoid profile.
- Confirm beta-caryophyllene appears in mg/g or a percentage.
- Match the batch number on the COA to the number on the bottle.
- Check the test date. Terpenes fade with heat and age.
- Pick reports from an ISO 17025 lab.
Frequently asked questions
Is caryophyllene the same as CBD?
No. Caryophyllene is a terpene with CB2 activity. CBD is a cannabinoid that acts on many targets. They often appear in the same extract but do different things.
Can caryophyllene replace a medication?
No. Talk to a clinician before using it as a substitute for, or an addition to, any prescription.
Which foods have the most beta-caryophyllene?
Black pepper, cloves, and copaiba oil sit near the top. Rosemary, oregano, cinnamon, and hops also carry it.
Does cooking destroy caryophyllene?
Heat and oxygen lower terpene content over time. Freshly ground pepper keeps more of it than pepper that sat in a jar for a year.
Key takeaways
Beta-caryophyllene outcomes trace back to CB2 activation and antioxidant activity. Evidence is strong in lab and animal work and thin in human trials. If you want it from a CBD product, buy from a brand that publishes a batch COA with a terpene panel.